Founded and headquartered in St. Louis, Missouri, Genus Medical is focused on developing imaging products that meet the clinical and economic needs of today’s healthcare environment. Our unique approach to supplying products creates quantifiable reductions in cost and streamlines operations, which ultimately improves patient satisfaction.
Genus Medical was founded on the belief that healthcare reform means more than the work taking place in our nation’s capital. We believe there is a need for companies to partner with healthcare providers, as part of a shared responsibility to provide greater value without compromising clinical excellence.
Ed Powers is President and CEO of Genus Medical Technologies. He previously served as Vice President of Corporate Accounts at Covidien Imaging, previously Mallinckrodt Imaging. He brings over 20 years of experience in the healthcare marketplace in various roles. He previously held positions at Covidien, Johnson and Johnson, and Smith and Nephew.
Dan Didier is Chief Scientific Officer of Genus Medical Technologies. He previously served as Head of Public Health for ThermoFisher Scientific. He brings over 30 years of experience in the scientific community. He previously held positions at Incyte, Cogent NeuroScience, Cytogenomics, Monsanto and Washington University School of Medicine.
Alicia Napoli is the Vice President of Quality at Genus Medical Technologies. She is a Clinical, Quality Assurance, Regulatory Affairs professional with over 35 years’ experience in the Pharmaceutical and Medical Device industry. She began her career with Baxter and has worked for Bristol Myers Squibb, Mallinckrodt and served as the Vice President of Clinical and Regulatory Affairs at Wright Medical. In her last position she was the Director of Quality and Regulatory Affairs at Bacterioscan.
Scott Gritz is the Director of Sales at Genus Medical Technologies. He has held a variety of sales, marketing, and sales management positions in the healthcare and related financial services sector for over 25 years.
Sign up for our Newsletter
Get the latest news on product offerings and upcoming events delivered to your inbox.Sign Up